SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-007994
Filing Date
2023-12-12
Accepted
2023-12-12 16:15:16
Documents
12
Period of Report
2023-12-08
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K organicell_8k.htm   iXBRL 8-K 34695
  Complete submission text file 0001829126-23-007994.txt   201266

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocel-20231208.xsd EX-101.SCH 2991
3 XBRL LABEL FILE ocel-20231208_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocel-20231208_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT organicell_8k_htm.xml XML 3044
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 231481400
SIC: 2836 Biological Products, (No Diagnostic Substances)